Archives

by in
Entry Author Date Location
Roger Perlmutter Returns to Merck, Looks to Biotech Future (Again) 03/07/13 New York
Ironwood Bucks the Trends, Makes Big Bet on Drug For Millions 02/06/13 Boston
Xconomist of the Week: Roger Perlmutter’s Parting Thoughts on Amgen 03/01/12 National
Amgen CEO Kevin Sharer’s Report Card: C 12/19/11 National
Amgen Confirms 380 Layoffs in R&D; Cuts Coming to Seattle, SF, Boston 10/19/11 National
Amgen Looking to Improve Focus and “Re-allocate Resources” for R&D, Say More Oct. 24 10/12/11 National
Radius Raises $91 Million to Advance Osteoporosis Drug, Makes Strides Towards Public Listing 05/24/11 Boston
Amgen Passes Key Trial With “Son of Dmab” For Osteoporosis 04/21/11 National
Where Are Tomorrow’s Blockbuster Biotech Drugs Coming From? You Might be Surprised 03/14/11 National
Fluidigm Completes IPO on 2nd Try, Geron CEO Exits, Amgen Pushes ‘Son of Dmab,’ & More Bay Area Life Sciences News 02/11/11 San Francisco
Stromedix Adds Debt to Finance Clinical Trial, Eliza and Google Team Up for Health IT Website, Arsanis Gets $10M, & More Boston-Area Life Sciences News 02/11/11 Boston
Amgen Pushes Ahead With ‘Son of Dmab’ For Treating Broken, Frail Bones 02/09/11 National
Amgen’s R&D Chief, Roger Perlmutter, on Why BioVex’s Cancer-Fighting Virus Is Worth $1B 01/26/11 Boston
One Big Cancer Story from 2010, and Four Trends to Watch in 2011 01/14/11 San Francisco
Northern California’s Top 5 Biotech Innovation News Stories 12/28/10 San Francisco
Dendreon Commercial Guy Leaves, Light Sciences CEO Exits, Amgen Wins FDA OK, & More Seattle-Area Life Sciences News 11/24/10 Seattle
Amgen Wins FDA OK For Cancer Drug 11/18/10 Seattle
Amgen, Abbott Win BayBio Awards 11/05/10 San Francisco
Biotech Drug Discovery in Seattle: A Look Back 06/11/10 Seattle
Amgen Gets FDA Approval, SonoSite’s New Frontier, Craig Venter’s Enabler, & More Seattle-Area Life Sciences News 06/03/10 Seattle
Amgen’s Dmab Wins FDA Approval 06/01/10 Seattle
A Brief Year-End Review of Seattle Biotech 12/31/09 Seattle
Five Red Flags of a Biotech, Pathway Medical Learns Lessons, Amgen Faces FDA Delay, & More Seattle-Area Life Sciences News 10/22/09 Seattle
Amgen’s Dmab Faces FDA Delay 10/19/09 Seattle
Amgen’s Seattle and Boston Teams Seek to Boost Biotech Hit Rate 20 to 30 Percent 10/09/09 National
Amgen’s Dmab Works in Cancer Trial 07/07/09 Seattle
Amgen Shows Off Cancer Drug Pipeline Before Scientific Meeting 04/16/09 National
Amgen Cuts 100 Jobs in Bothell 04/09/09 Seattle
ZymoGenetics Trial Halted, Amgen’s Big New Drug, Spiration Gets FDA Nod, & More Seattle-Area Life Sciences News 10/30/08 Seattle
Amgen Scientist, After 13-Year Push, Sees Bone Cancer Work Paying Dividends 10/29/08 Seattle
Page 1 of 2 next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  3. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  4. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  5. Do You Need an Extended Warranty? Do the Math, Says SquareTrade

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.